{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:17:03Z","timestamp":1791325023453,"version":"4.3.1"},"reference-count":106,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2019.00345","type":"journal-article","created":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T08:27:28Z","timestamp":1564043248000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":129,"title":["Metabolic Disorders and Male Hypogonadotropic Hypogonadism"],"prefix":"10.3389","volume":"10","author":[{"given":"Rosario","family":"Pivonello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Menafra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Riccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Garifalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Mazzella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"de Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Colao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,7,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/S0140-6736(13)61126-5","article-title":"Male hypogonadism","volume":"383","author":"Basaria","year":"2014","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"569","DOI":"10.14310\/horm.2002.1635","article-title":"Hypogonadism as a possible link between metabolic diseases and erectile dysfunction in aging men","volume":"14","author":"Corona","year":"2015","journal-title":"Hormones (Athens)."},{"key":"B3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1530\/EJE-17-0065","article-title":"Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH)","volume":"178","author":"Bonomi","year":"2018","journal-title":"Eur J Endocrinol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.mcna.2011.03.001","article-title":"Late-onset hypogonadism","volume":"95","author":"Bassil","year":"2011","journal-title":"Med Clin North Am."},{"key":"B5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/14740338.2018.1424831","article-title":"The safety of available treatments of male hypogonadism in organic and functional hypogonadism","volume":"17","author":"Corona","year":"2018","journal-title":"Expert Opin Drug Saf."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1210\/jc.2016-3580","article-title":"A perspective on middle-aged and older men with functional hypogonadism: focus on holistic management","volume":"102","author":"Grossmann","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"key":"B7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.5694\/mja16.00393","article-title":"Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy","volume":"205","author":"Yeap","year":"2016","journal-title":"Med J Aust."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e100409","DOI":"10.1371\/journal.pone.0100409","article-title":"Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies","volume":"9","author":"Brand","year":"","journal-title":"PLoS ONE."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1210\/jc.2008-0054","article-title":"Inverse association of testosterone and the metabolic syndrome in men is consistent across race and ethnic groups","volume":"93","author":"Kupelian","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"B10","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1210\/jc.2005-1326","article-title":"Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men","volume":"91","author":"Kupelian","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.2337\/diacare.27.5.1036","article-title":"Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men","volume":"27","author":"Laaksonen","year":"2004","journal-title":"Diabetes Care."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1001\/jama.295.11.1288","article-title":"Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis","volume":"295","author":"Ding","year":"2006","journal-title":"JAMA."},{"key":"B13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2337\/diacare.25.1.55","article-title":"Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study","volume":"25","author":"Oh","year":"2002","journal-title":"Diabetes Care."},{"key":"B14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3109\/13685538.2010.487553","article-title":"Prevalence, incidence and risk factors of testosterone deficiency in a population-based cohort of men: results from the study of health in Pomerania","volume":"13","author":"Haring","year":"2010","journal-title":"Aging Male."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1210\/jc.2015-1571","article-title":"Development of and recovery from secondary hypogonadism in aging men: prospective results from the EMAS","volume":"100","author":"Rastrelli","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"key":"B16","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1210\/jc.2004-0970","article-title":"The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study","volume":"90","author":"Laaksonen","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"B17","doi-asserted-by":"publisher","first-page":"807","DOI":"10.7326\/0003-4819-117-10-807","article-title":"Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus","volume":"117","author":"Barrett-Connor","year":"1992","journal-title":"Ann Intern Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1365-2605.2010.01117.x","article-title":"Type 2 diabetes mellitus and testosterone: a meta-analysis study","volume":"34","author":"Corona","year":"2011","journal-title":"Int J Androl."},{"key":"B19","doi-asserted-by":"publisher","first-page":"5462","DOI":"10.1210\/jc.2004-0804","article-title":"Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes","volume":"89","author":"Dhindsa","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.2337\/dc06-0197","article-title":"Contrasting testosterone concentrations in type 1 and type 2 diabetes","volume":"29","author":"Tomar","year":"2006","journal-title":"Diabetes Care."},{"key":"B21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.beem.2013.05.002","article-title":"Diagnosis and treatment of late-onset hypogonadism: systematic review and meta-analysis of TRT outcomes","volume":"27","author":"Corona","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"B22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/aja.2011.138","article-title":"How to recognize late-onset hypogonadism in men with sexual dysfunction","volume":"14","author":"Corona","year":"2012","journal-title":"Asian J Androl."},{"key":"B23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.mce.2015.06.031","article-title":"Obesity and late-onset hypogonadism","volume":"418","author":"Corona","year":"2015","journal-title":"Mol Cell Endocrinol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.sxmr.2017.09.004","article-title":"Alternatives to testosterone therapy: a review","volume":"6","author":"Lo","year":"2018","journal-title":"Sex Med Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/and.12366","article-title":"Effect of metformin therapy and dietary supplements on semen parameters in hyperinsulinaemic males","volume":"47","author":"Bosman","year":"2015","journal-title":"Andrologia."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.fertnstert.2010.12.009","article-title":"Metformin improves semen characteristics of oligo-teratoasthenozoospermic men with metabolic syndrome","volume":"95","author":"Morgante","year":"2011","journal-title":"Fertil Steril."},{"key":"B27","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1530\/EJE-08-0601","article-title":"Investigation, treatment and monitoring of late-onset hypogonadismin males: ISA, ISSAM, EAU, EAA and ASA recommendations","volume":"159","author":"Wang","year":"2008","journal-title":"Eur J Endocrinol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2337\/dc06-1426","article-title":"Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity","volume":"30","author":"Kapoor","year":"2007","journal-title":"Diabetes Care."},{"key":"B29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0026-0495(97)90299-7","article-title":"Evidence for sex steroid inhibition of lipoprotein lipase in men: comparison of abdominal and femoral adipose tissue","volume":"46","author":"Ramirez","year":"1997","journal-title":"Metabolism."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.2337\/diacare.28.7.1636","article-title":"Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men","volume":"28","author":"Pitteloud","year":"2005","journal-title":"Diabetes Care."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1126\/science.289.5487.2122","article-title":"Role of brain insulin receptor in control of body weight and reproduction","volume":"289","author":"Br\u00fcning","year":"2000","journal-title":"Science."},{"key":"B32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1054\/mehy.1997.0624","article-title":"The hypogonadal-obesity cycle: role of aromatase in modulating the testosterone-estradiol shunt\u2013a major factor in the genesis of morbid obesity","volume":"52","author":"Cohen","year":"1999","journal-title":"Med Hypotheses."},{"key":"B33","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1046\/j.1365-2826.2001.00632.x","article-title":"The in vitro role of tumor necrosis factor-alpha and interleukin-6 in the hypothalamic-pituitary gonadal axis","volume":"13","author":"Russell","year":"2001","journal-title":"J Neuroendocrinol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"4868","DOI":"10.1210\/en.2003-0644","article-title":"Hypothalamic interleukin-1 beta and tumor necrosis factor-alpha, but not interleukin-6, mediate the endotoxin induced suppression of the reproductive axis in rats","volume":"144","author":"Watanobe","year":"2003","journal-title":"Endocrinology."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1210\/jcem.84.10.6082","article-title":"Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels","volume":"84","author":"Isidori","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"key":"B36","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s12020-018-1646-9","article-title":"Downregulation of leptin receptor and kisspeptin\/GPR54 in the murine hypothalamus contributes to male hypogonadism caused by high-fat diet-induced obesity","volume":"62","author":"Zhai","year":"2018","journal-title":"Endocrine."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1210\/jcem-45-6-1211","article-title":"Low serum testosterone and sex-hormone-binding-globulin in massively obese men","volume":"45","author":"Glass","year":"1977","journal-title":"J Clin Endocrinol Metab."},{"key":"B38","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2337\/diacare.17.5.405","article-title":"Testosterone concentrations in women and men with NIDDM","volume":"17","author":"Andersson","year":"1994","journal-title":"Diabetes Care."},{"key":"B39","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.tem.2015.05.001","article-title":"Novel insights in SHBG regulation and clinical implications","volume":"26","author":"Simo","year":"2015","journal-title":"Trends Endocrinol Metab."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e0200078","DOI":"10.1371\/journal.pone.0200078","article-title":"Cross-sectional and longitudinal determinants of serum sex hormone binding globulin (SHBG) in a cohort of community-dwelling men","volume":"13","author":"Gyawali","year":"2018","journal-title":"PLoS ONE."},{"key":"B41","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/cen.12092","article-title":"The role of obesity and type 2 diabetes mellitus in the development of male obesity-associated secondary hypogonadism","volume":"78","author":"Saboor Aftab","year":"2013","journal-title":"Clin Endocrinol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.2337\/diacare.26.6.1812","article-title":"Steroids in adult men with type 1 diabetes: a tendency to hypogonadism","volume":"26","author":"van Dam","year":"2003","journal-title":"Diabetes Care."},{"key":"B43","doi-asserted-by":"publisher","first-page":"4254","DOI":"10.1210\/jc.2007-0454","article-title":"Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism","volume":"92","author":"Yialamas","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"B44","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000485998","article-title":"The metabolic syndrome in central hypogonadotrophic hypogonadism","volume":"49","author":"Dwyer","year":"2018","journal-title":"Front Horm Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1210\/jc.86.9.4261","article-title":"The effects of induced hypogonadismon arterial stiffness, body composition, and metabolic parameters in males with prostate cancer","volume":"86","author":"Smith","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"key":"B46","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/annonc\/mdn458","article-title":"Treatment-related diabetes and cardiovascular disease in prostate cancer survivors","volume":"19","author":"Smith","year":"2008","journal-title":"Ann Oncol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1210\/jcem.87.2.8299","article-title":"Changes in body composition during androgen deprivation therapy for prostate cancer","volume":"87","author":"Smith","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1210\/jc.2005-2507","article-title":"Insulin sensitivity during combined androgen blockade for prostate cancer","volume":"91","author":"Smith","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e0117344","DOI":"10.1371\/journal.pone.0117344","article-title":"Quantifying the evidence for the risk of metabolic syndrome and its components following androgen deprivation therapy for prostate cancer: a meta-analysis","volume":"10","author":"Bosco","year":"2015","journal-title":"PLoS ONE."},{"key":"B50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/jnci\/djp404","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer","volume":"102","author":"Keating","year":"2010","journal-title":"J Natl Cancer Inst."},{"key":"B51","first-page":"1040","article-title":"Hypogonadism in metabolic syndrome: cause or consequence? Lesson from genetic hypogonadism and disorders of gender identity","volume":"2","author":"Mancini","year":"2014","journal-title":"J Endocrinol Diabetes Obes."},{"key":"B52","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/obr.12282","article-title":"Testosterone and obesity","volume":"16","author":"Kelly","year":"2015","journal-title":"Obes Rev."},{"key":"B53","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1210\/jcem.79.4.7962311","article-title":"Pathogenesis of the decreased androgen levels in obese men","volume":"79","author":"Giagulli","year":"1994","journal-title":"J Clin Endocrinol Metab."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1210\/jcem.76.5.8496304","article-title":"Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men","volume":"76","author":"Vermeulen","year":"1993","journal-title":"J Clin Endocrinol Metab."},{"key":"B55","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1365-2265.2005.02339.x","article-title":"Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis","volume":"63","author":"Isidori","year":"2005","journal-title":"Clin Endocrinol (Oxf)."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1210\/jcem.85.3.6427","article-title":"Contribution of body fatness and adipose tissue distribution to the age variation in plasma steroid hormone concentrations in men: the HERITAGE Family","volume":"85","author":"Couillard","year":"2000","journal-title":"Study J Clin Endocrinol Metab."},{"key":"B57","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/0026-0495(90)90297-P","article-title":"Visceral fat accumulation in men is positively associated with insulin, glucose, and C peptide levels, but negatively with testosterone levels","volume":"39","author":"Seidell","year":"1990","journal-title":"Metabolism."},{"key":"B58","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2214\/ajr.170.2.9456958","article-title":"Using quantitative CT to assess adipose distribution in adult men with acquired hypogonadism","volume":"170","author":"Katznelson","year":"1998","journal-title":"Am J Roentgenol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/0026-0495(94)90202-X","article-title":"Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men","volume":"43","author":"Haffner","year":"1994","journal-title":"Metabolism."},{"key":"B60","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/0026-0495(93)90181-M","article-title":"Relationship between serum sex hormones and the glucose-insulin-lipid defect in men with obesity","volume":"42","author":"Phillips","year":"1993","journal-title":"Metabolism."},{"key":"B61","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/BF00402551","article-title":"Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study","volume":"35","author":"Simon","year":"1992","journal-title":"Diabetologia."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.juro.2006.06.003","article-title":"The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men?","volume":"176","author":"Kaplan","year":"2006","journal-title":"J Urol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1210\/jcem-71-4-929","article-title":"Plasma free and non-sex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity","volume":"71","author":"Zumoff","year":"1990","journal-title":"J Clin Endocrinol Metab."},{"key":"B64","doi-asserted-by":"publisher","first-page":"212","DOI":"10.2337\/diabetes.43.2.212","article-title":"Insulin resistance, body fat distribution, and sex hormones in men","volume":"43","author":"Haffner","year":"1994","journal-title":"Diabetes."},{"key":"B65","first-page":"233","article-title":"Pituitary testicular axis in diabetic men with and without sexual impotence","volume":"4","author":"Daubresse","year":"1978","journal-title":"Diabetes Metab."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1210\/jc.2007-2177","article-title":"Low testosterone levels are common and associated with insulin resistance in men with diabetes","volume":"93","author":"Grossmann","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"B67","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1365-2605.2009.00965.x","article-title":"Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes?","volume":"32","author":"Corona","year":"2009","journal-title":"Int J Androl."},{"key":"B68","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1089\/154041903321648270","article-title":"Hypogonadotropic hypogonadism in erectile dysfunction associated with type 2 diabetes mellitus: a common defect?","volume":"1","author":"Tripathy","year":"2003","journal-title":"Metab Syndr Relat Disord."},{"key":"B69","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/j.1742-1241.2006.00992.x","article-title":"Prevalence of hypogonadism in males aged at least 45 years: the HIM study","volume":"60","author":"Mulligan","year":"2006","journal-title":"Int J Clin Pract."},{"key":"B70","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1530\/eje.0.1490601","article-title":"Sex hormones, inflammation and the metabolic syndrome: a population-based study","volume":"149","author":"Laaksonen","year":"2003","journal-title":"Eur J Endocrinol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2337\/diacare.27.4.861","article-title":"Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat","volume":"27","author":"Tsai","year":"2004","journal-title":"Diabetes Care."},{"key":"B72","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1080\/00365510801999068","article-title":"Impact of testosterone treatment on postprandial triglyceride metabolism in elderly men with subnormal testosterone levels","volume":"68","author":"Agledahl","year":"2008","journal-title":"Scand J Clin Lab Invest."},{"key":"B73","first-page":"329","article-title":"Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues","volume":"1","author":"Marin","year":"1992","journal-title":"Eur J Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1210\/jc.80.1.239","article-title":"Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens","volume":"80","author":"Marin","year":"1995","journal-title":"J Clin Endocrinol Metab."},{"key":"B75","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/01485010701730880","article-title":"An exploratory study of the effects of 12 month administration of the novel long-acting testosterone undecanoate on measures of sexual function and the metabolic syndrome","volume":"53","author":"Saad","year":"2007","journal-title":"Arch Androl."},{"key":"B76","first-page":"991","article-title":"The effects of testosterone treatment on body composition and metabolism in middle-aged obese men","volume":"16","author":"M\u00e5rin","year":"1992","journal-title":"Int J Obes Relat Metab Disord."},{"key":"B77","doi-asserted-by":"publisher","first-page":"146","DOI":"10.4103\/1008-682X.122346","article-title":"Metabolic effects of testosterone replacement therapy on hypogonadal men with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Cai","year":"2014","journal-title":"Asian J Androl."},{"key":"B78","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2164\/jandrol.107.002774","article-title":"A dose-response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate","volume":"29","author":"Saad","year":"2008","journal-title":"J Androl."},{"key":"B79","doi-asserted-by":"publisher","first-page":"726","DOI":"10.2164\/jandrol.108.007005","article-title":"Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone","volume":"30","author":"Heufelder","year":"2009","journal-title":"J Androl."},{"key":"B80","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/j.1365-2265.2010.03845.x","article-title":"Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study","volume":"73","author":"Kalinchenko","year":"2010","journal-title":"Clin Endocrinol (Oxf)."},{"key":"B81","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1210\/jc.82.2.407","article-title":"Testosterone replacement increases fat-free mass and muscle size in hypogonadal men","volume":"82","author":"Bhasin","year":"1997","journal-title":"J Clin Endocrinol Metab."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1210\/jc.85.8.2670","article-title":"Effects of testosterone replacement in hypogonadal men","volume":"85","author":"Snyder","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"key":"B83","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.1210\/jcem.81.10.8855818","article-title":"Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men\u2013a clinical research center study","volume":"81","author":"Wang","year":"1996","journal-title":"J Clin Endocrinol Metab."},{"key":"B84","first-page":"614","article-title":"Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men","volume":"19","author":"Lovejoy","year":"1995","journal-title":"Int J Obes Relat Metab Disord."},{"key":"B85","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/ijir.2008.19","article-title":"Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip","volume":"20","author":"Svartberg","year":"2008","journal-title":"Int J Impot Res."},{"key":"B86","doi-asserted-by":"publisher","first-page":"3604","DOI":"10.1210\/jcem.86.8.7773","article-title":"Effects of GH and\/or sex steroid administration on abdominal subcutaneous and visceral fat in healthy aged women and men","volume":"86","author":"M\u00fcnzer","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"key":"B87","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1210\/jc.2003-031492","article-title":"Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men","volume":"89","author":"Woodhouse","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"key":"B88","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1210\/jc.2007-1291","article-title":"Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men","volume":"93","author":"Allan","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"B89","doi-asserted-by":"publisher","first-page":"4358","DOI":"10.1210\/jcem.81.12.8954042","article-title":"Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism","volume":"81","author":"Katznelson","year":"1996","journal-title":"J Clin Endocrinol Metab."},{"key":"B90","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1210\/jc.84.8.2647","article-title":"Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age","volume":"84","author":"Snyder","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"key":"B91","doi-asserted-by":"publisher","first-page":"E120","DOI":"10.1152\/ajpendo.00363.2002","article-title":"Effects of an oral androgen on muscle and metabolism in older, community-dwelling men","volume":"284","author":"Schroeder","year":"2003","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"B92","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.1210\/jc.2004-0784","article-title":"Effects of androgen therapy on adipose tissue and metabolism in older men","volume":"89","author":"Schroeder","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"key":"B93","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1530\/EJE-17-0673","article-title":"Diminished androgen and estrogen receptors and aromatase levels in hypogonadal diabetic men: reversal with testosterone","volume":"178","author":"Ghanim","year":"2018","journal-title":"Eur J Endocrinol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.2337\/diacare.24.12.2149","article-title":"Androgen therapy improves insulin sensitivity and decreases leptin level in healthy adult men with low plasma total testosterone: a 3-month randomized placebo-controlled trial","volume":"24","author":"Simon","year":"2001","journal-title":"Diabetes Care."},{"key":"B95","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1530\/eje.1.02166","article-title":"Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes","volume":"154","author":"Kapoor","year":"2006","journal-title":"Eur J Endocrinol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2337\/dc15-1518","article-title":"Insulin resistance and inflammation in hypogonadotropic hypogonadism and their reduction after testosterone replacement in men with type 2","volume":"39","author":"Dhindsa","year":"2016","journal-title":"Diabetes Diabetes Care."},{"key":"B97","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1210\/jcem-68-5-971","article-title":"The administration of pharmacological doses of testosterone or 19-nortestosterone to normal men is not associated with increased insulin secretion or impaired glucose tolerance","volume":"68","author":"Friedl","year":"1989","journal-title":"J Clin Endocrinol Metab."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1210\/jc.2017-02545","article-title":"Long-term testosterone administration on insulin sensitivity in older men with low or low-normal testosterone levels","volume":"103","author":"Huang","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"key":"B99","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.metabol.2003.12.016","article-title":"Partial androgen deficiency in aging type 2 diabeticmen and its relationship to glycemic control","volume":"53","author":"Corrales","year":"2004","journal-title":"Metabolism."},{"key":"B100","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1055\/s-2007-978950","article-title":"Effect of testosterone replacement on whole body glucose utilization and other cardiovascular risk factors in males with idiopathic hypogonadotrophic hypogonadism","volume":"30","author":"Tripathy","year":"1998","journal-title":"Horm Metab Res."},{"key":"B101","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1530\/EJE-12-0955","article-title":"Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis","volume":"168","author":"Corona","year":"2013","journal-title":"Eur J Endocrinol."},{"key":"B102","first-page":"145","article-title":"Effects of metformin and short-term lifestyle modification on the improvement of male hypogonadism associated with metabolic syndrome","volume":"35","author":"Casulari","year":"2010","journal-title":"Minerva Endocrinol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3132\/dvdr.2008.022","article-title":"Rosiglitazone increases bioactive testosterone and reduces waist circumference in hypogonadal men with type 2 diabetes","volume":"5","author":"Kapoor","year":"2008","journal-title":"Diab Vasc Dis Res."},{"key":"B104","doi-asserted-by":"publisher","first-page":"e13039","DOI":"10.1111\/and.13039","article-title":"Short-term combined treatment with exenatide and metformin is superior to glimepiride combined metformin in improvement of serum testosterone levels in type 2 diabetic patients with obesity","volume":"50","author":"Shao","year":"2018","journal-title":"Andrologia."},{"key":"B105","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1530\/EC-18-0514","article-title":"Effects of liraglutide on obesity-associated functional hypogonadism in men","volume":"8","author":"Jensterle","year":"2019","journal-title":"Endocr Connect."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/andr.12099","article-title":"Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism","volume":"3","author":"Giagulli","year":"2015","journal-title":"Andrology."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00345\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T08:27:32Z","timestamp":1564043252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00345\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,25]]},"references-count":106,"alternative-id":["10.3389\/fendo.2019.00345"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2019.00345","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,25]]},"article-number":"345"}}